Chimera Research Group
  • About – Who We Are
    • Our Team
    • Subscription Service
    • Video Tour
    • Contact Us
  • Blog – Free Reports
  • Tools – Premium Access
    • Biotech M&A – 2025 Deals
    • Biotech M&A – 2024 Deals
    • Biotech M&A – 2023 Deals
    • Biotech M&A – 2022 Deals
    • Biotech M&A – 2021 Deals
    • Biotech M&A – 2020 Deals
    • Biotech M&A – 2019 Deals
    • Biotech M&A – 2018 Deals
    • Clinical Holds – 2022
    • Direct Email
    • Real-Time Tweets
    • Real-Time Email Alerts
    • Team Positions
    • FAQ
  • All Reports – Premium Research
    • Daily Update
    • Research Reports
    • Charts & TA
    • Trade Reports
    • Tutorials
  • Forum – Exchange Insight
  • About – Who We Are
    • Our Team
    • Subscription Service
    • Video Tour
    • Contact Us
  • Blog – Free Reports
  • Tools – Premium Access
    • Biotech M&A – 2025 Deals
    • Biotech M&A – 2024 Deals
    • Biotech M&A – 2023 Deals
    • Biotech M&A – 2022 Deals
    • Biotech M&A – 2021 Deals
    • Biotech M&A – 2020 Deals
    • Biotech M&A – 2019 Deals
    • Biotech M&A – 2018 Deals
    • Clinical Holds – 2022
    • Direct Email
    • Real-Time Tweets
    • Real-Time Email Alerts
    • Team Positions
    • FAQ
  • All Reports – Premium Research
    • Daily Update
    • Research Reports
    • Charts & TA
    • Trade Reports
    • Tutorials
  • Forum – Exchange Insight

CNVIF

Conavi Is Revolutionizing Coronary Interventions

I’ve primarily been focused on biotech stocks and have generally avoided medical device investments. But a month ago, a broker I’ve worked with for years called me about a new opportunity. He knows I’m selective, but he was excited about the company and wanted my take on their public financing round. When he mentioned it […]

By Joe Gantoss Jun 10, 2025
In Research Reports

Press

© Copyright 2025 Chimera Research Group, Inc Disclaimer Disclosures Ethics Policy Privacy Policy Terms & Conditions

Log In

JoinLost Password?
  • Join Now
  • LoginClose